gene therapy - search results

Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...

CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients

A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease

Jon Snaedal, professor in Geriatric Medicine, Landspitali University Hospital in Reykjavik, Iceland shares his expertise on dementia research including the early diagnosis of brain disorders

The work of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, including muscular dystrophy (MD), is placed under the spotlight by Open Access Government

Chief Executive of Anxiety UK, Nicky Lidbetter lifts the lid on the relief and rehabilitation of persons affected by agoraphobia and associated anxiety disorders, phobias and conditions and the extent to which these are treatable and manageable

Donald A. Mahler from the Geisel School of Medicine at Dartmouth and Clinical Resource Center of the Alpha-1 Foundation and Valley Regional Hospital, on behalf of the CHEST Foundation, provides an expert view on shortness of breath (dyspnea)

Dr Michael A Rudnicki, CEO & Scientific Director at the Stem Cell Network gives an expert view on a new era in health care, powered by stem cells

Eigil Kjeldsen from Aarhus University Hospital gives an expert perspective on the drive towards precision and targeted medicine for acute leukaemia

Cecilia Van Cauwenberghe, from TechVision Group, Frost & Sullivan provides a fascinating overview of acute respiratory distress syndrome, including refocusing clinical concerns and disease management, as well as the overall characteristics and health implications

New research by the National Institutes of Health challenge common practice of increasing doses at early signs of worsening symptoms in asthma

Grazina Berry from Aplastic Anaemia Trust, along with Professor Judith Marsh and Dr Shreyans Gandhi from King’s College Hospital NHS Foundation Trust, explore the rare and serious condition of aplastic anaemia (AA)

Jonathan Evans, communications manager at the Association of British Healthcare Industries explains the need to innovate when it comes to using digital technologies for the delivery of healthcare in the UK.

New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells character­ised by the appearance of immature, abnormal myeloid cells in bone marrow and other...

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. It is a rapidly progressing form of leukaemia. Blood cells are formed...

Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease From the time it was first described in the mid-nineteenth century, the cause and treatment of Pernicious Anaemia became the subject of some of the most inquisitive...

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography The Murray and Nadel’s Textbook of Respiratory Medicine (Schwartzstein and Adams, 2016), etymologically defines dyspnoea from the Greek dys (painful, difficult) and pneuma (breath). Clinically, dyspnoea constitutes a medical...